IMVT

Immunovant Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↓ 2/10
  • Momentum↑ 8/10
Immunovant sales and earnings growth
IMVT Growth
Fair
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↓ -2.29%
  • FCF Y/Y↓ -29.92%
Immunovant gross and profit margin trends
IMVT Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC↑ 24724.60%
Immunovant net debt vs free cash flow
IMVT Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Immunovant stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗